The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Regulatory News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

9 Nov 2016 09:36

RNS Number : 7388O
Diurnal Group PLC
09 November 2016
 

9 November 2016

 

Diurnal Group plc

("Diurnal" or the "Company")

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them in accordance with the Market Abuse Regulations.

 

On 8 November 2016 the following par value options over ordinary shares of 5 pence in Diurnal were granted under the Diurnal Group plc Long Term Incentive Plan (the "Plan") to persons discharging managerial responsibilities ("PDMR"):

 

PDMR

Total no. of shares under award

Type of awards

Martin Whitaker

133,333

Performance Share Award

Martin Whitaker

69,565

Deferred Bonus Award

Ian Ardill

81,250

Performance Share Award

Ian Ardill

22,608

Deferred Bonus Award

 

The performance share awards will ordinarily vest no earlier than the third anniversary of their grant subject to the grantee's continued service and to the extent to which the performance conditions set for the awards are satisfied. Such awards may potentially vest until the fifth anniversary of their grant date.

 

The deferred bonus awards will ordinarily vest on the first anniversary of their grant subject to the grantee's continued service.

 

The awards were granted under award agreements that incorporated the terms of the Plan and comprised a mix of tax-favoured 'EMI' awards and non-tax favoured awards.

 

The exercise price payable per share under award is par value presently being 5 pence per ordinary share.

 

Details of the full notifications received by the Company are set out below:

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Martin Whitaker

2

Reason for Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Diurnal Group plc

b)

LEI

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 5 pence each in Diurnal Group plc

GB00BDB6Q760

b)

Nature of the transaction

Grant of awards under the Diurnal Group plc Long Term Incentive Plan as par value options as follows:

 

Non-EMI performance share award over 133,333 ordinary shares.

 

EMI deferred bonus award over 9,730 ordinary shares.

 

Non-EMI deferred bonus award over 59,835 ordinary shares.

 

The performance share award will ordinarily vest no earlier than the third anniversary of its grant subject to continued service and to the extent to which the performance conditions set for the awards are satisfied. Such award may potentially vest until the fifth anniversary of its grant date.

 

The deferred bonus awards will ordinarily vest on the first anniversary of their grant subject to continued service.

 

The exercise price payable per share under award is par value presently being 5 pence per ordinary share.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

133,333

Nil

9,730

Nil

59,835

d)

Aggregated information

- Aggregated volume

- Price

Award over total of 202,898 ordinary shares. Nil price payable for grant.

e)

Date of the transaction

8 November 2016

f)

Place of the transaction

Outside a trading venue

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ian Ardill

2

Reason for Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Diurnal Group plc

b)

LEI

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 5 pence each in Diurnal Group plc

GB00BDB6Q760

b)

Nature of the transaction

Grant of awards under the Diurnal Group plc Long Term Incentive Plan as par value options as follows:

 

EMI performance share award over 53,323 ordinary shares.

 

Non-EMI performance share award over 27,927 ordinary shares.

 

EMI deferred bonus award over 22,608 ordinary shares.

 

The performance share awards will ordinarily vest no earlier than the third anniversary of their grant subject to continued service and to the extent to which the performance conditions set for the awards are satisfied. Such awards may potentially vest until the fifth anniversary of their grant date.

 

The deferred bonus award will ordinarily vest on the first anniversary of its grant subject to continued service.

 

The exercise price payable per share under award is par value presently being 5 pence per ordinary share.

 

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

53,323

Nil

27,927

Nil

22,608

d)

Aggregated information

- Aggregated volume

- Price

Award over total of 103,858 ordinary shares. Nil price payable for grant.

e)

Date of the transaction

8 November 2016

f)

Place of the transaction

Outside a trading venue

 

 

 

For further information, please visit www.diurnal.co.uk or contact:

Diurnal Group plc

+44 (0)20 3727 1000

Martin Whitaker, CEO

Ian Ardill, CFO

Numis Securities Ltd (Nominated Adviser)

+44 (0)20 7260 1000

Nominated Adviser: Michael Meade, Freddie Barnfield, Paul Gillam

Corporate Broking: James Black

FTI Consulting

+44 (0)20 3727 1000

Simon Conway

Victoria Foster Mitchell

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFSMSUUFMSEDF
Date   Source Headline
7th Sep 202212:00 pmRNSForm 8.5 (EPT/RI) - Diurnal Group plc
7th Sep 20229:58 amRNSForm 8.5 (EPT/RI)
7th Sep 20229:23 amRNSMole Valley Asset Management Ltd-Form 8.3 Diurnal
6th Sep 20221:36 pmRNSForm 8.5 (EPT/RI) - Diurnal Group plc
6th Sep 202212:00 pmRNSForm 8.5 (EPT/RI) - Diurnal Group plc
6th Sep 20229:04 amRNSForm 8.3 - [DIURNAL GROUP PLC]
5th Sep 20223:16 pmRNSForm 8.3 - Diurnal Group Plc
5th Sep 20221:36 pmRNSForm 8 (OPD) (Diurnal Group)
5th Sep 202212:00 pmRNSForm 8.5 (EPT/RI) - Diurnal Group plc
2nd Sep 20224:28 pmRNSForm 8 (OPD) (Neurocrine Biosciences, Inc.)
2nd Sep 20222:55 pmRNSForm 8.3 - Diurnal Group plc
2nd Sep 202212:00 pmRNSForm 8.5 (EPT/RI) - Diurnal Group plc
2nd Sep 20228:58 amRNSForm 8.5 (EPT/RI)
1st Sep 20223:12 pmRNSForm 8.3 - Diurnal Group plc
1st Sep 20221:20 pmRNSForm 8.3 - Diurnal Group Plc
1st Sep 202212:00 pmRNSForm 8.5 (EPT/RI) - Diurnal Group plc
1st Sep 202210:04 amRNSForm 8.5 (EPT/RI)
1st Sep 20229:38 amRNSForm 8.3 - [DIURNAL GROUP PLC]
1st Sep 20227:00 amRNSPostponement of R&D Day and Notice of Results
31st Aug 20223:20 pmRNSForm 8.3 - Diurnal Group plc
31st Aug 20222:03 pmRNSForm 8.3 - Diurnal Group PLC
31st Aug 202212:53 pmRNSForm 8.3 DIURNAL GROUP PLC
31st Aug 202212:00 pmRNSForm 8.5 (EPT/RI) - Diurnal Group plc
31st Aug 202211:56 amRNSForm 8.5 (EPT/RI) - Diurnal Group PLC
31st Aug 202211:55 amRNSForm 8.3 - Diurnal Group plc
31st Aug 202211:46 amGNWForm 8.3 - [Diurnal Group plc - 30 08 2022 - Opening Declaration] - (HHL)
31st Aug 20229:08 amRNSForm 8.3 - Diurnal Group PLC
30th Aug 202212:55 pmRNSForm 8.3 - DIURNAL GROUP PLC
30th Aug 202212:32 pmEQSForm 8.3 - Maitland Institutional Services Limited: Re Diurnal Group plc
30th Aug 20227:00 amRNSRECOMMENDED CASH ACQUISITION
26th Jul 20227:00 amRNSTrading Update
15th Jul 202212:04 pmRNSDirector Dealings
30th Jun 20221:29 pmRNSBlock Listing Six Monthly Return
7th Jun 20221:00 pmRNSDiurnal to present research at ENDO 2022
1st Jun 20227:00 amRNSFirst patient dosed in pivotal Phase 3 trial
23rd May 20228:41 amRNSCorrection: Presentation at ECE
23rd May 20227:00 amRNSPresentation at European Congress of Endocrinology
9th May 202212:49 pmRNSDirector Dealings
29th Apr 20223:37 pmRNSTotal Voting Rights
28th Apr 20227:00 amRNSDiurnal to present at Investor Evening
25th Apr 20227:00 amRNSDistribution agreement signed with EffRx
20th Apr 20227:00 amRNSDistribution agreement signed with Er-Kim
4th Apr 20227:00 amRNSDirectorate Change and Management Updates
1st Apr 20227:00 amRNSTotal Voting Rights
30th Mar 20227:00 amRNSDistribution agreement with Vector Pharma
22nd Mar 20224:35 pmRNSPrice Monitoring Extension
22nd Mar 20222:06 pmRNSSecond Price Monitoring Extn
22nd Mar 20222:00 pmRNSPrice Monitoring Extension
22nd Mar 20227:00 amRNSInterim Results
9th Mar 20227:00 amRNSInterim Results Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.